HeartBeam director granted 17,241 RSUs

Nelson Kenneth Warwick III reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Nelson Kenneth Warwick III reported acquisition or exercise transactions in this Form 4 filing.

HeartBeam, Inc. director Nelson Kenneth Warwick III reported a compensation grant of 17,241 restricted stock units (RSUs) of common stock. These RSUs were granted on February 9, 2026 at no cash cost and increase his direct holdings to 144,388 shares.

According to the grant terms, one half of the RSUs will vest on March 31, 2026, and the remaining half will vest on June 30, 2026, based on a vesting commencement date of January 1, 2026. The award was issued under HeartBeam’s 2022 Equity Incentive Plan, highlighting routine equity-based director compensation rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 17,241 shares

Grant/Award 1 txn

Insider Nelson Kenneth Warwick III

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	17,241	$0.00	$0.00

Holdings After Transaction: Common Stock — 144,388 shares (Direct)

Footnotes (1)

1. F1. These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HeartBeam (BEAT) disclose for Nelson Kenneth Warwick III?

HeartBeam reported a grant of 17,241 restricted stock units (RSUs) of common stock to director Nelson Kenneth Warwick III. The award is equity compensation, not an open-market share purchase, and was made under the company’s 2022 Equity Incentive Plan at no cash cost per unit.

How many HeartBeam (BEAT) shares does Nelson Kenneth Warwick III hold after this Form 4?

After the RSU grant, Nelson Kenneth Warwick III holds 144,388 shares of HeartBeam common stock directly. This total includes the newly granted 17,241 RSUs, which will convert into shares as they vest, reflecting his overall equity exposure as a company director.

What are the vesting terms of the 17,241 RSUs granted by HeartBeam (BEAT)?

The 17,241 RSUs vest in two equal installments tied to a January 1, 2026 commencement date. Half of the units vest on March 31, 2026, and the remaining half vest on June 30, 2026, assuming applicable service or other vesting conditions are satisfied through those dates.

Is the HeartBeam (BEAT) RSU grant to Nelson Kenneth Warwick III a market purchase?

No, the transaction is an equity award, not a market purchase. The Form 4 shows a grant of restricted stock units at a price of $0.0000 per unit, indicating compensation awarded under HeartBeam’s 2022 Equity Incentive Plan rather than shares bought on the open market.

Which plan did HeartBeam (BEAT) use for the RSU grant to its director?

The RSUs granted to Nelson Kenneth Warwick III were issued under HeartBeam’s 2022 Equity Incentive Plan. This plan provides stock-based compensation, such as restricted stock units, to directors and other eligible participants to align their interests with long-term shareholder value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 05:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nelson Kenneth Warwick III

(Last) (First) (Middle)

2118 WALSH AVENUE, SUITE 210

15TH FL

(Street)

SANTA CLARA CALIFORNIA 95050

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		17,241	A	$0	144,388	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.

	/s/ Kenneth Warwick Nelson III	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)